Roche: gets EU approval for haemophilia A drug
(CercleFinance.com) - Swiss drugmaker Roche has received approval from the European Commission for Hemlibra for the treatment of people with haemophilia A with inhibitors.
The drug is the first new medicine to be approved in over 20 years to treat people with haemophilia A with inhibitors in Europe, the company said.
People with haemophilia A with inhibitors have a 70% higher risk of death compared to those without inhibitors.
The drug is already marketed in the US for people with haemophilia A with factor VIII inhibitors.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
The drug is the first new medicine to be approved in over 20 years to treat people with haemophilia A with inhibitors in Europe, the company said.
People with haemophilia A with inhibitors have a 70% higher risk of death compared to those without inhibitors.
The drug is already marketed in the US for people with haemophilia A with factor VIII inhibitors.
Copyright (c) 2018 CercleFinance.com. All rights reserved.